An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease

Underrated and neglected, talaromycosis is a life-threatening fungal disease endemic to the tropical and subtropical regions of Asia. In China, it has been reported that talaromycosis mortality doubles from 24 to 50% when the diagnosis is delayed, and reaches 100% when the diagnosis is missed. Thus,...

Full description

Bibliographic Details
Main Authors:	Silvere D. Zaongo, Fazhen Zhang, Yaokai Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Journal of Fungi
Subjects:	<i>T. marneffei</i> talaromycosis diagnosis treatment prognosis
Online Access:	https://www.mdpi.com/2309-608X/9/6/647

Similar Items

Clinical features of HIV positive talaromycosis marneffei patients and development of a risk prediction model
by: Jiemei Cen, et al.
Published: (2023-09-01)

Clinical performance of metagenomic next-generation sequencing for the rapid diagnosis of talaromycosis in HIV-infected patients
by: Yuhuan Mao, et al.
Published: (2022-10-01)

Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study
by: Yihong Zhou, et al.
Published: (2023-10-01)

Clinical Characteristics Associated with Poor Prognosis of Acquired Immunodeficiency Syndrome Patients Complicated with Disseminated Talaromycosis marneffei
by: Wu L, et al.
Published: (2023-11-01)

Talaromycosis from Wuhan: two-case report and literature review
by: Zhiyuan Yao, et al.
Published: (2024-03-01)

Gastrointestinal Talaromyces marneffei infection in a patient with AIDS: A case report and systematic review
by: Fangmei Ling, et al.
Published: (2022-09-01)

A case of TM infection with challenging differential diagnosis from lymphoma post-renal transplant
by: Sulin Luo, et al.
Published: (2023-12-01)

Analysis of 133 dead cases of AIDS patients co-infected with Talaromycosis
by: CHEN Zhimin, LIU Bo, He Haolan, HE Yaozu, FENG Lizhi, LIU Xinhua, ZHANG Jiansheng, CAI Weiping, LI Linghua
Published: (2022-08-01)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
by: Zhiwen Jiang, et al.
Published: (2022-09-01)

Disseminated talaromycosis with presentations of painful oral ulcers and generalized papules in a 44-year-old man with advanced HIV infection
by: Te-Yao Hsueh, et al.
Published: (2023-08-01)

Case series to depict the outcomes of commonly available laboratory investigations in molluscum-like skin lesions among HIV positive patients
by: Pradeep Balasubramanian, et al.
Published: (2023-01-01)

Brain Nocardiosis and Pulmonary Talaromycosis Infection in a Patient with Anti-IFN-γ Autoantibodies: A Case Report
by: Wu S, et al.
Published: (2023-08-01)

Expression of Cytokine Profiles in Human THP-1 Cells during Phase Transition of <i>Talaromyces marneffei</i>
by: Fangyi Shu, et al.
Published: (2022-12-01)

Ultrasound characterization of superficial lymph nodes in HIV patients with Talaromyces marneffei infection
by: Lin Pan, et al.
Published: (2023-12-01)

Pulmonary Talaromyces marneffei misdiagnosed as smear‐negative pulmonary tuberculosis
by: Xiaojuan Chen, et al.
Published: (2023-08-01)

The clinical and environmental epidemiology of Penicillium marneffei infection in Vietnam
by: Le, T
Published: (2015)

Disseminated Talaromyces marneffei infection after renal transplantation: A case report and literature review
by: Liang Xu, et al.
Published: (2023-02-01)

Role of <i>acuK</i> in Control of Iron Acquisition and Gluconeogenesis in <i>Talaromyces marneffei</i>
by: Artid Amsri, et al.
Published: (2021-09-01)

An Overview of Endometrial Cancer with Novel Therapeutic Strategies
by: Theresa M. Kuhn, et al.
Published: (2023-08-01)

CT findings of Talaromyces marneffei infection among HIV patients with lymphadenopathy
by: Xiao-ling Zhu, et al.
Published: (2022-07-01)

Antifungal Activity and Molecular Mechanisms of Partial Purified Antifungal Proteins from <i>Rhinacanthus nasutus</i> against <i>Talaromyces marneffei</i>
by: Juthatip Jeenkeawpieam, et al.
Published: (2020-12-01)

<i>Talaromyces amestolkiae</i> Infection in an AIDS Patient with Cryptococcal Meningitis
by: Li-An Wang, et al.
Published: (2023-09-01)

Comparison of in vitro Susceptibilities of Talaromyces marneffei in Mold and Yeast Forms in Malaysia
by: Tan XT, et al.
Published: (2023-03-01)

Cytological Diagnosis of Penicillium marneffei Infection
by: I-Shiow Jan, et al.
Published: (2008-06-01)

Polyketides, Toxins and Pigments in Penicillium marneffei
by: Emily W. T. Tam, et al.
Published: (2015-10-01)

Genetic Engineering of <i>Talaromyces marneffei</i> to Enhance Siderophore Production and Preliminary Testing for Medical Application Potential
by: Artid Amsri, et al.
Published: (2022-11-01)

New Polyene Macrolide Compounds from Mangrove-Derived Strain <i>Streptomyces hiroshimensis</i> GXIMD 06359: Isolation, Antifungal Activity, and Mechanism against <i>Talaromyces marneffei</i>
by: Zhou Wang, et al.
Published: (2024-01-01)

Coexisting of Primary Central Nervous System Lymphoma and Talaromyces marneffei Brain Abscess in an AIDS Patient, A Case Report and Review of the Literature
by: Liu X, et al.
Published: (2024-02-01)

Clinical characteristics of tracheobronchial Talaromyces marneffei infection in non-HIV-infected patients in South China
by: Mianluan Pan, et al.
Published: (2023-12-01)

Talaromyces marneffei Genomic, Transcriptomic, Proteomic and Metabolomic Studies Reveal Mechanisms for Environmental Adaptations and Virulence
by: Susanna K. P. Lau, et al.
Published: (2017-06-01)

Talaromyces marneffei infection associated with bronchiolitis obliterans in an HIV-negative child: a case report
by: Lin Lin, et al.
Published: (2022-05-01)

<i>RAC1</i>, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
by: Xue Wu, et al.
Published: (2022-12-01)

<i>Talaromyces marneffei</i> Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms
by: Kritsada Pruksaphon, et al.
Published: (2022-02-01)

Talaromyces marneffei endocarditis initially detected by Next Generation Sequencing: A case report
by: Youqi Ji, et al.
Published: (2024-03-01)

PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review
by: Silvere D. Zaongo, et al.
Published: (2023-10-01)

Anticytokine Autoantibodies and Fungal Infections
by: Shanthi Kappagoda, et al.
Published: (2023-07-01)

Exosomes released from macrophages infected with Talaromyces marneffei activate the innate immune responses and decrease the replication
by: Guangquan Ji, et al.
Published: (2023-06-01)

HIV-Negative Case of Talaromyces marneffei Pulmonary Infection with Liver Cirrhosis in China: A Case Report and Literature Review
by: Liu Y, et al.
Published: (2024-04-01)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
by: Junjun Jiang, et al.
Published: (2019-01-01)

Osteoarticular infection caused by Talaromyces Marneffei and Salmonella in a person living with HIV: a case report
by: Lele Yu, et al.
Published: (2023-08-01)